Decision making with regard to thromboprophylaxis should be based upon the absolute
risks of stroke/thromboembolism and bleeding and the net clinical benefit for a given patient …

The risk of stroke in atrial fibrillation (AF) needs to be assessed in each patient to determine
the clinical and cost-effectiveness of thromboprophylaxis, with the aim of appropriate use of …

Atrial fibrillation (AF) is the commonest sustained cardiac rhythm disorder, which is
associated with a substantial risk of mortality and morbidity arising from stroke and …

Optimal stroke prevention using oral anticoagulant (OAC) therapy is essential for the
management of patients with atrial fibrillation (AF) who are at increased risk of stroke, but …

Stroke prevention is central to the management of patients with atrial fibrillation (AF). As
effective stroke prophylaxis essentially requires oral anticoagulants, an understanding of the …

Stroke prevention with appropriate thromboprophylaxis still remains central to the
management of atrial fibrillation (AF). Nonetheless, stroke risk in AF is not homogeneous …

Objectives We identified factors associated with thromboembolic and bleeding events in two
contemporary cohorts of anticoagulated patients with atrial fibrillation (AF), treated with …

Stroke prevention is central to the management of atrial fibrillation (AF), and effective
thromboprophylaxis requires oral anticoagulation. Even a single stroke risk factor confers …

Despite the clear net clinical benefit of oral anticoagulation (OAC) in atrial fibrillation (AF)
patients at risk for stroke, major bleeding events (especially intra-cranial bleeds) may be …

Atrial fibrillation (AF) significantly increases the risk of stroke and, therefore, stroke
prevention is an essential component of the management for patients with AF. This requires …